InvestorsHub Logo
Followers 21
Posts 2233
Boards Moderated 0
Alias Born 02/22/2005

Re: None

Tuesday, 09/09/2008 1:35:54 PM

Tuesday, September 09, 2008 1:35:54 PM

Post# of 346122
Duke / Peregrine anti-PS quote ----------

SK: "We're also continuing multiple preclinical collaborations in the anti-viral area. In particular, our collaboration with researchers at Duke and other institutions testing our anti-PS antibodies continues to yield valuable insights into the potential of this technology platform in HIV, and I am happy to report that data from this collaboration will be highlighted this fall at the prestigeous AIDS Vaccine 2008 conference to be held in Cape Town South Africa from October 13th to the 16th. This will mark the first time that data from our collaboration has been presented, and we are very pleased with the opportunity to share the information with the broader scientific community. These collaborations have allowed us to make considerable progress in understanding the potential of our anti-PS technology platform for the treatment and possible prevention of serious virus infections, and have only served to heighten our excitement over the antiviral potential of this platform."


---------------


HIV TREATMENT......



Who's been paying for this work so far?

The Gates Foundation has.



j







Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News